vs
Encompass Health Corp（EHC）与RANGE RESOURCES CORP（RRC）财务数据对比。点击上方公司名可切换其他公司
Encompass Health Corp的季度营收约是RANGE RESOURCES CORP的2.0倍（$1.5B vs $786.9M），RANGE RESOURCES CORP净利率更高（22.8% vs 9.5%，领先13.3%），RANGE RESOURCES CORP同比增速更快（18.0% vs 9.9%），过去两年RANGE RESOURCES CORP的营收复合增速更高（14.6% vs 8.3%）
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
Range Resources Corporation是一家总部位于美国得克萨斯州沃斯堡的天然气勘探开采企业，核心运营区域为马塞勒斯页岩地层，是该地区拥有土地面积最大的运营商，专注于天然气资源的勘探、开发与生产业务，在北美油气开发领域具备深厚的行业积累。
EHC vs RRC — 直观对比
营收规模更大
EHC
是对方的2.0倍
$786.9M
营收增速更快
RRC
高出8.0%
9.9%
净利率更高
RRC
高出13.3%
9.5%
两年增速更快
RRC
近两年复合增速
8.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $786.9M |
| 净利润 | $146.1M | $179.1M |
| 毛利率 | — | 94.5% |
| 营业利润率 | 16.7% | — |
| 净利率 | 9.5% | 22.8% |
| 营收同比 | 9.9% | 18.0% |
| 净利润同比 | 20.8% | 88.8% |
| 每股收益（稀释后） | $1.43 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EHCRRC
| Q4 25 | $1.5B | $786.9M | ||
| Q3 25 | $1.5B | $655.3M | ||
| Q2 25 | $1.5B | $699.6M | ||
| Q1 25 | $1.5B | $846.3M | ||
| Q4 24 | $1.4B | $667.0M | ||
| Q3 24 | $1.4B | $567.9M | ||
| Q2 24 | $1.3B | $513.2M | ||
| Q1 24 | $1.3B | $598.8M |
净利润EHCRRC
| Q4 25 | $146.1M | $179.1M | ||
| Q3 25 | $126.5M | $144.3M | ||
| Q2 25 | $142.1M | $237.6M | ||
| Q1 25 | $151.5M | $97.1M | ||
| Q4 24 | $120.9M | $94.8M | ||
| Q3 24 | $108.2M | $50.7M | ||
| Q2 24 | $114.1M | $28.7M | ||
| Q1 24 | $112.5M | $92.1M |
毛利率EHCRRC
| Q4 25 | — | 94.5% | ||
| Q3 25 | — | 92.5% | ||
| Q2 25 | — | 95.0% | ||
| Q1 25 | — | 93.1% | ||
| Q4 24 | — | 93.7% | ||
| Q3 24 | — | 94.3% | ||
| Q2 24 | — | 93.4% | ||
| Q1 24 | — | 94.7% |
营业利润率EHCRRC
| Q4 25 | 16.7% | — | ||
| Q3 25 | 14.9% | — | ||
| Q2 25 | 16.2% | — | ||
| Q1 25 | 16.4% | — | ||
| Q4 24 | 14.3% | — | ||
| Q3 24 | 13.6% | — | ||
| Q2 24 | 14.3% | — | ||
| Q1 24 | 13.6% | — |
净利率EHCRRC
| Q4 25 | 9.5% | 22.8% | ||
| Q3 25 | 8.6% | 22.0% | ||
| Q2 25 | 9.7% | 34.0% | ||
| Q1 25 | 10.4% | 11.5% | ||
| Q4 24 | 8.6% | 14.2% | ||
| Q3 24 | 8.0% | 8.9% | ||
| Q2 24 | 8.8% | 5.6% | ||
| Q1 24 | 8.5% | 15.4% |
每股收益（稀释后）EHCRRC
| Q4 25 | $1.43 | $0.75 | ||
| Q3 25 | $1.24 | $0.60 | ||
| Q2 25 | $1.39 | $0.99 | ||
| Q1 25 | $1.48 | $0.40 | ||
| Q4 24 | $1.18 | $0.38 | ||
| Q3 24 | $1.06 | $0.21 | ||
| Q2 24 | $1.12 | $0.12 | ||
| Q1 24 | $1.10 | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.2M | $204.0K |
| 总债务越低越好 | $2.4B | $1.2B |
| 股东权益账面价值 | $2.4B | $4.3B |
| 总资产 | $7.1B | $7.4B |
| 负债/权益比越低杠杆越低 | 1.00× | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资EHCRRC
| Q4 25 | $72.2M | $204.0K | ||
| Q3 25 | $48.7M | $175.0K | ||
| Q2 25 | $99.1M | $134.0K | ||
| Q1 25 | $95.8M | $344.6M | ||
| Q4 24 | $85.4M | $304.5M | ||
| Q3 24 | $147.8M | $277.4M | ||
| Q2 24 | $154.4M | $251.1M | ||
| Q1 24 | $134.4M | $343.1M |
总债务EHCRRC
| Q4 25 | $2.4B | $1.2B | ||
| Q3 25 | $2.4B | $1.2B | ||
| Q2 25 | $2.3B | $1.2B | ||
| Q1 25 | $2.3B | $1.7B | ||
| Q4 24 | $2.4B | $1.7B | ||
| Q3 24 | $2.3B | $1.7B | ||
| Q2 24 | $2.7B | $1.7B | ||
| Q1 24 | $2.7B | $1.8B |
股东权益EHCRRC
| Q4 25 | $2.4B | $4.3B | ||
| Q3 25 | $2.4B | $4.2B | ||
| Q2 25 | $2.3B | $4.1B | ||
| Q1 25 | $2.2B | $3.9B | ||
| Q4 24 | $2.1B | $3.9B | ||
| Q3 24 | $2.0B | $3.9B | ||
| Q2 24 | $1.8B | $3.9B | ||
| Q1 24 | $1.7B | $3.8B |
总资产EHCRRC
| Q4 25 | $7.1B | $7.4B | ||
| Q3 25 | $6.9B | $7.2B | ||
| Q2 25 | $6.8B | $7.1B | ||
| Q1 25 | $6.6B | $7.4B | ||
| Q4 24 | $6.5B | $7.3B | ||
| Q3 24 | $6.5B | $7.2B | ||
| Q2 24 | $6.4B | $7.3B | ||
| Q1 24 | $6.2B | $7.4B |
负债/权益比EHCRRC
| Q4 25 | 1.00× | 0.28× | ||
| Q3 25 | 1.01× | 0.29× | ||
| Q2 25 | 1.02× | 0.29× | ||
| Q1 25 | 1.08× | 0.43× | ||
| Q4 24 | 1.14× | 0.43× | ||
| Q3 24 | 1.20× | 0.44× | ||
| Q2 24 | 1.46× | 0.44× | ||
| Q1 24 | 1.54× | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $346.0M | $257.5M |
| 自由现金流经营现金流 - 资本支出 | $116.7M | — |
| 自由现金流率自由现金流/营收 | 7.6% | — |
| 资本支出强度资本支出/营收 | 14.8% | — |
| 现金转化率经营现金流/净利润 | 2.37× | 1.44× |
| 过去12个月自由现金流最近4个季度 | $439.2M | — |
8季度趋势，按日历期对齐
经营现金流EHCRRC
| Q4 25 | $346.0M | $257.5M | ||
| Q3 25 | $270.8M | $247.5M | ||
| Q2 25 | $270.2M | $336.2M | ||
| Q1 25 | $288.6M | $330.1M | ||
| Q4 24 | $278.8M | $217.9M | ||
| Q3 24 | $267.8M | $245.9M | ||
| Q2 24 | $217.4M | $148.8M | ||
| Q1 24 | $238.8M | $331.9M |
自由现金流EHCRRC
| Q4 25 | $116.7M | — | ||
| Q3 25 | $83.7M | — | ||
| Q2 25 | $113.3M | — | ||
| Q1 25 | $125.5M | — | ||
| Q4 24 | $80.1M | — | ||
| Q3 24 | $120.3M | — | ||
| Q2 24 | $60.5M | — | ||
| Q1 24 | $99.4M | — |
自由现金流率EHCRRC
| Q4 25 | 7.6% | — | ||
| Q3 25 | 5.7% | — | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | 8.6% | — | ||
| Q4 24 | 5.7% | — | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | 4.6% | — | ||
| Q1 24 | 7.6% | — |
资本支出强度EHCRRC
| Q4 25 | 14.8% | — | ||
| Q3 25 | 12.7% | — | ||
| Q2 25 | 10.8% | — | ||
| Q1 25 | 11.2% | — | ||
| Q4 24 | 14.1% | — | ||
| Q3 24 | 10.9% | — | ||
| Q2 24 | 12.1% | — | ||
| Q1 24 | 10.6% | — |
现金转化率EHCRRC
| Q4 25 | 2.37× | 1.44× | ||
| Q3 25 | 2.14× | 1.72× | ||
| Q2 25 | 1.90× | 1.42× | ||
| Q1 25 | 1.90× | 3.40× | ||
| Q4 24 | 2.31× | 2.30× | ||
| Q3 24 | 2.48× | 4.85× | ||
| Q2 24 | 1.91× | 5.18× | ||
| Q1 24 | 2.12× | 3.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
